These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 16567769

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ.
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic/pharmacodynamic modeling and simulation of neutropenia during phase I development of liposome-entrapped paclitaxel.
    Fetterly GJ, Grasela TH, Sherman JW, Dul JL, Grahn A, Lecomte D, Fiedler-Kelly J, Damjanov N, Fishman M, Kane MP, Rubin EH, Tan AR.
    Clin Cancer Res; 2008 Sep 15; 14(18):5856-63. PubMed ID: 18794097
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prospective evaluation of the pharmacokinetics and toxicity profile of docetaxel in the elderly.
    ten Tije AJ, Verweij J, Carducci MA, Graveland W, Rogers T, Pronk T, Verbruggen MP, Dawkins F, Baker SD.
    J Clin Oncol; 2005 Feb 20; 23(6):1070-7. PubMed ID: 15718305
    [Abstract] [Full Text] [Related]

  • 14. Phase I trial of oral MAC-321 in subjects with advanced malignant solid tumors.
    Lockhart AC, Bukowski R, Rothenberg ML, Wang KK, Cooper W, Grover J, Appleman L, Mayer PR, Shapiro M, Zhu AX.
    Cancer Chemother Pharmacol; 2007 Jul 20; 60(2):203-9. PubMed ID: 17091249
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic drug monitoring of paclitaxel (Zisu) in cancer patients.
    Wu D, Liang Y, Liu Q.
    J Environ Pathol Toxicol Oncol; 2000 Jul 20; 19(1-2):77-80. PubMed ID: 10905511
    [Abstract] [Full Text] [Related]

  • 16. Phase I targeted systemic exposure study of paclitaxel in children with refractory acute leukemias.
    Woo MH, Relling MV, Sonnichsen DS, Rivera GK, Pratt CB, Pui CH, Evans WE, Pappo AS.
    Clin Cancer Res; 1999 Mar 20; 5(3):543-9. PubMed ID: 10100705
    [Abstract] [Full Text] [Related]

  • 17. Indirect-response model for the time course of leukopenia with anticancer drugs.
    Minami H, Sasaki Y, Saijo N, Ohtsu T, Fujii H, Igarashi T, Itoh K.
    Clin Pharmacol Ther; 1998 Nov 20; 64(5):511-21. PubMed ID: 9834043
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Relationship of systemic exposure to unbound docetaxel and neutropenia.
    Baker SD, Li J, ten Tije AJ, Figg WD, Graveland W, Verweij J, Sparreboom A.
    Clin Pharmacol Ther; 2005 Jan 20; 77(1):43-53. PubMed ID: 15637530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.